Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Are advanced glycation end products cardiovascular risk factors in patients with CRF?Günter Stein, Martin Busch, Andreas Müller, et al.Current Diabetes Reports|November 13, 2003
New treatments for diabetic neuropathy: pathogenetically oriented treatmentAngelika Bierhaus, Per M Humpert, Gottfried Rudofsky, et al.Current Atherosclerosis Reports|April 5, 2002
Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetesThoralf Wendt, Loredana Bucciarelli, Wu Qu, et al.Circulation Research|March 8, 2008
Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end productsJong Sun Chang, Thoralf Wendt, Wu Qu, et al.Antioxidants & Redox Signaling|December 17, 2005
Diabetic vascular disease: it's all the RAGEBarry I Hudson, Thoralf Wendt, Loredana G Bucciarelli, et al.Journal of Molecular Medicine (Berlin, Germany)|September 1, 2005
Understanding RAGE, the receptor for advanced glycation end productsAngelika Bierhaus, Per M Humpert, Michael Morcos, et al.Kidney International|January 12, 2002
Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin IIJens H Gerth, Jörg Kriegsmann, T Tong Trinh, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2004
RAGE axis: Animal models and novel insights into the vascular complications of diabetesYoshifumi Naka, Loredana G Bucciarelli, Thoralf Wendt, et al.Herz|September 2, 2004
[AGE-RAGE: a hypothesis or a mechanism?]Berend Isermann, Angelika Bierhaus, Per M Humpert, et al.Atherosclerosis|August 4, 2005
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetesThoralf Wendt, Evis Harja, Loredana Bucciarelli, et al.Pageof 2